On the role of protoporphyrin IX photoproducts in photodynamic therapy
β Scribed by E.F.Gudgin Dickson; R.H. Pottier
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 254 KB
- Volume
- 29
- Category
- Article
- ISSN
- 1011-1344
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Photodynamic therapy (pdt) is an experimental approach for treating prostate cancer localized to the gland that does not involve surgery or irradiation. second-generation photosensitizers 5-aminolevulinic acid (ala) and aluminum disulfonated phthalocyanine (als2pc) were studied in th
## Abstract ## Objective Accurate dosimetry was shown to be critical to achieve effective photodynamic therapy (PDT). This study aimed to assess the reliability of in vivo protoporphyrin IX (PpIX) fluorescence photobleaching as a predictive tool of the hexaminolevulinate PDT (HALβPDT) response in
Background and Objective: Cancer of the pancreas constitutes one of the major causes of cancer related death throughout the world. A 5-year survival rate of only 2% and a maximum of 20 months median survival in multi modality treatment studies dealing with the most favorable patients only, has been
## Abstract Photodynamic therapy (PDT) is used to treat malignant and nonmalignant diseases. It is also used for cosmetological skin treatment. PDT is generally considered to have a low risk of carcinogenicity. However, instances of nonmalignant human tumors turning malignant have been linked to PD